Inhibitory activity of avibactam against selected β-lactamases expressed in an isogenic Escherichia coli strain

Diagnostic Microbiology and Infectious Disease

Volumn 86, Issue 1, 2016, Pages 83-85

  Giani, Tommaso ^a   Cannatelli, Antonio ^a   Di Pilato, Vincenzo ^b   Testa, Raymond ^c   Nichols, Wright W ^c   Rossolini, Gian Maria ^a,d,e,f  

^a UNIVERSITY OF SIENA   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c ASTRAZENECA   (United Kingdom)

^d UNIVERSITY OF FLORENCE   (Italy)

^e CAREGGI UNIVERSITY HOSPITAL   (Italy)

^f IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

Author keywords

AmpC type lactamases; Avibactam lactam combinations; Carbapenemases; extended spectrum lactamases; Lactamase inhibition

Indexed keywords

AVIBACTAM; AZTREONAM; BETA LACTAMASE; CARBAPENEMASE; CEFTAROLINE; CEFTAZIDIME; ANTIINFECTIVE AGENT; AZABICYCLO DERIVATIVE; BETA LACTAMASE INHIBITOR; CEPHALOSPORIN DERIVATIVE;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; DRUG EFFECT; ESCHERICHIA COLI; GENETIC CODE; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR CLONING; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN EXPRESSION; DRUG EFFECTS; ENZYMOLOGY; GENE EXPRESSION; GENETICS; HUMAN; METABOLISM; MICROBIAL SENSITIVITY TEST;

ANTI-BACTERIAL AGENTS; AZABICYCLO COMPOUNDS; AZTREONAM; BETA-LACTAMASE INHIBITORS; BETA-LACTAMASES; CEFTAZIDIME; CEPHALOSPORINS; ESCHERICHIA COLI; GENE EXPRESSION; HUMANS; MICROBIAL SENSITIVITY TESTS;

EID: 84979660389     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2016.03.002     Document Type: Article

References (24)

1. Arpin, C., Labia, R., Dubois, V., Noury, P., Souquet, M., Quentin, C., TEM-80, a novel inhibitor-resistant β-lactamase in a clinical isolate of Enterobacter cloacae. Antimicrob Agents Chemother 46 (2002), 1183–1189.
2. Bonnet, R., Sampaio, J.L., Labia, R., De Champs, C., Sirot, D., Chanal, C., et al. A novel CTX-M β-lactamase (CTX-M-8) in cefotaxime-resistant Enterobacteriaceae isolated in Brazil. Antimicrob Agents Chemother 44 (2000), 1936–1942.
3. Borgianni, L., Vandenameele, J., Matagne, A., Bini, L., Bonomo, R.A., Frère, J.M., et al. Mutational analysis of VIM-2 reveals an essential determinant for metallo-β-lactamase stability and folding. Antimicrob Agents Chemother 54 (2010), 3197–3204.
4. Bradford, P.A., Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 4 (2001), 933–951.
5. Camargo, J.F., Simkins, J., Beduschi, T., Tekin, A., Aragon, L., Pérez-Cardona, A., et al. Successful treatment of carbapenemase-producing pandrug-resistant Klebsiella pneumoniae bacteremia. Antimicrob Agents Chemother 59 (2015), 5903–5908.
6. Clinical Laboratory Standards Institute (CLSI), Methods for dilution antimicrobial susceptibility. Tests for bacteria that grow aerobically; Approved standard, Tenth ed. CLSI document M07-A10, 2015, CLSI, Wayne, PA.
7. Coleman, K., Diazabicyclooctanes (DBOs): a potent new class of non-β-lactam β-lactamase inhibitors. Curr Opin Microbiol 14 (2011), 550–555.
8. Drawz, S.M., Papp-Wallace, K.M., Bonomo, R.A., New β-Lactamase inhibitors: a therapeutic renaissance in an MDR World. Antimicrob Agents Chemother 58 (2014), 1835–1846.
9. Ehmann, D.E., Jahić, H., Ross, P.L., Gu, R.F., Hu, J., Durand-Réville, T.F., et al. Kinetics of avibactam inhibition against class A, C, and D β-lactamases. J Biol Chem 288 (2013), 27960–27971.
10. Endimiani, A., Choudhary, Y., Bonomo, R.A., In vitro activity of NXL104 in combination with β-lactams against Klebsiella pneumoniae isolates producing KPC carbapenemases. Antimicrob Agents Chemother 53 (2009), 3599–3601.
11. VIM, a new integron-borne metallo- β-lactamase gene from a Pseudomonas aeruginosa clinical isolate. Antimicrob Agents Chemother 43 (1999), 1584–1590.
12. Livermore, D.M., Mushtaq, S., Barker, K., Hope, R., Warner, M., Woodford, N., Characterization of β-lactamase and porin mutants of Enterobacteriaceae selected with ceftaroline + avibactam (NXL104). J Antimicrob Chemother 67 (2012), 1354–1358.
13. Monaco, M., Giani, T., Raffone, M., Arena, F., Garcia-Fernandez, A., Pollini, S., et al. Colistin resistance superimposed to endemic carbapenem-resistant Klebsiella pneumoniae: a rapidly evolving problem in Italy, November 2013 to April 2014. Euro Surveill, 19, 2014.
14. Nordmann, P., Poirel, L., The difficult-to-control spread of carbapenemase producers among Enterobacteriaceae worldwide. Clin Microbiol Infect 20 (2014), 821–830.
15. Normark, S., Burman, L.G., Resistance of Escherichia coli to penicillins: fine-structure mapping and dominance of chromosomal β-lactamase mutations. J Bacteriol 132 (1977), 1–7.
16. Papp-Wallace, K.M., Bajaksouzian, S., Abdelhamed, A.M., Foster, A.N., Winkler, M.L., Gatta, J.A., et al. Activities of ceftazidime, ceftaroline, and aztreonam alone and combined with avibactam against isogenic Escherichia coli strains expressing selected single β-lactamases. Diagn Microbiol Infect Dis 82 (2015), 65–69.
17. Perilli, M., Segatore, B., de Massis, M.R., Riccio, M.L., Bianchi, C., Zollo, A., et al. TEM-72, a new extended-spectrum β-lactamase detected in Proteus mirabilis and Morganella morganii in Italy. Antimicrob Agents Chemother 44 (2000), 2537–2539.
18. Perilli, M., Segatore, B., Mugnaioli, C., Celenza, G., Rossolini, G.M., Stefani, S., et al. Persistence of TEM-52/TEM-92 and SHV-12 extended-spectrum β-lactamases in clinical isolates of Enterobacteriaceae in Italy. Microb Drug Resist 17 (2011), 521–524.
19. Rossolini, G.M., Arena, F., Pecile, P., Pollini, S., Update on the antibiotic resistance crisis. Curr Opin Pharmacol 18 (2014), 56–60.
20. Sambrook, J., Russel, D.W., Molecular cloning: a laboratory manual. CSHN, (eds.), 2001, Cold Spring Harbor Laboratory Press.
21. The European Committee on Antimicrobial Susceptibility Testing (EUCAST), Breakpoint tables for interpretation of MICs and zone diameters. Version 5.0, 2015. Available from http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Breakpoint_tables/v_5.0_Breakpoint_Table_01.pdf.
22. Welsh, K.J., Barlow, M., Tenover, F.C., Biddle, J.W., Rasheed, J.K., Clark, L.A., et al. Experimental prediction of the evolution of ceftazidime resistance in the CTX-M-2 extended-spectrum β-lactamase. Antimicrob Agents Chemother 49 (2005), 1242–1244.
23. Zhanel, G.G., Lawson, C.D., Adam, H., Schweizer, F., Zelenitsky, S., Lagacé-Wiens, P.R.S., et al. Ceftazidime-avibactam: a novel cephalosporin/β-lactamase inhibitor combination. Drugs 73 (2013), 159–177.
24. Zheng, L., Baumann, U., Reymond, J.L., An efficient one-step site-directed and site-saturation mutagenesis protocol. Nucleic Acids Res, 32, 2004, e115.